Outlook Therapeutics Receives FDA Agreement for 3 Special Protocol Assessments
03 Dec 2019 //
GLOBE NEWWIRE
Outlook Therapeutics closes enrolment in Phase III wet AMD study
21 Aug 2019 //
CLINICALTRIAL SARENA
03 Dec 2019 //
GLOBE NEWWIRE
21 Aug 2019 //
CLINICALTRIAL SARENA
Market Place
Sourcing Support